HADCORP

Home

Implant Research

Dr Ostermeyer's Research

Neoplasms & Implants

Platinum Testing

Children and Silicone

About Breast Implants

Alternative Implants

Suicide and Implants

Implants and the FDA

Implants in the UK

Silicone Immune Protocol

Biotoxins

MCS

Implant Identification

Implant Photos

Orthopaedic Implants

Board of Directors

Medical Device News

Glossary

Implant Resources

Contact Us

Members
 

Knowledge Empowers   


Published in Rheumatology, Volume 23, Number 3,  Pp. 227-229    

case-report    

POST-MAMMOPLASTY HUMAN ADJUVANT DISEASE

M. A. BYRON1, V. A. VENNING2 and A. G. MOWAT1

1Department of Rheumatology, Nuffield Orthopaedic Centre Headington, Oxford 0X3 7LD
2Department of Dermatology, Churchill Hospital Headington, Oxford

Correspondence to: Address correspondence to Dr. M. A. Byron.

Morphoea and keratoconjunctivitis sicca developed in a woman with seronegative rheumatoid arthritis six years after augmentation mammoplasty. Previous reports of post-mammoplasty connective tissue disease have followed the use of silicone gel, whereas the more ‘biologically inert’ saline-filled silastic implants were used in this case.

KEY WORDS: Mammoplasty, Silicone, Adjuvant disease, Morphoea

© 1984 British Society for Rheumatology





Implant Research

 

The information on this website is presented for educational purposes by the Human Adjuvant Disease Corp.